A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
In Modern Era, Recurrent Desmoids Determine Outcome in Patients With Gardner Syndrome: A Cohort Study of Three Generations of an Adenomatous Polyposis Coli (APC-) Mutation-Positive Family Across 30 Years
1 other identifier
observational
105
0 countries
N/A
Brief Summary
The purpose of this study is to assess the long-term outcome in a cohort of Gardner-Syndrome patients receiving prophylaxis and treatment for intestinal and non-intestinal tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 1978
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1978
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 25, 2011
CompletedFirst Posted
Study publicly available on registry
January 31, 2011
CompletedJanuary 31, 2011
January 1, 2011
32.9 years
January 25, 2011
January 27, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality
1978-2010 (as long as patients live)
Secondary Outcomes (2)
incidence of colorectal carcinoma
1978-2010 (entire patient life)
Incidence of desmoid tumors
1978-2010 (entire patient life)
Eligibility Criteria
Since 1978, we have been following a family of 105 descendants with Gardner syndrom. APC (adenomatous polyposis coli) mutation carriers were screened by endoscopy, and colorectal resection was performed upon pending malignancy. Desmoid tumors were treated by excision or radiotherapy and brachytherapy.
You may qualify if:
- family with an identical adenomatous polyposis coli (APC-) germ line mutation
You may not qualify if:
- negative testing for adenomatous polyposis coli (APC-) germ line mutation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Triemli Hospitallead
Related Publications (1)
Turina M, Pavlik CM, Heinimann K, Behrensmeier F, Simmen HP. Recurrent desmoids determine outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-positive family across 30 years. Int J Colorectal Dis. 2013 Jun;28(6):865-72. doi: 10.1007/s00384-012-1600-x. Epub 2012 Nov 1.
PMID: 23114473DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Turina, MD PhD
Triemli Hospital
- STUDY DIRECTOR
Hans P Simmen, MD
University of Zurich Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 25, 2011
First Posted
January 31, 2011
Study Start
January 1, 1978
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
January 31, 2011
Record last verified: 2011-01